Column Group IV, LP — insider trades

Stock trades Column Group IV, LP reported on SEC Form 4 at EIKN Eikon Therapeutics, Inc..

• Sep 3, 2026: bought 89,200 shares of EIKN Eikon Therapeutics, Inc. ($1.03M)
• Feb 6, 2026: bought 2,117,760 shares of EIKN Eikon Therapeutics, Inc. ($38.1M)